Supernus Pharmaceuticals
SUPN
#4507
Rank
S$3.15 B
Marketcap
S$54.20
Share price
0.47%
Change (1 day)
-13.01%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: S$3.15 Billion

As of October 2026 Supernus Pharmaceuticals has a market cap of S$3.15 Billion. This makes Supernus Pharmaceuticals the world's 4507th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026S$3.15 B-16.88%
2025S$3.79 B36.04%
2024S$2.79 B33.64%
2023S$2.08 B-19.22%
2022S$2.58 B23.3%
2021S$2.09 B19.14%
2020S$1.75 B4.75%
2019S$1.67 B-29.24%
2018S$2.37 B-13.1%
2017S$2.73 B50.92%
2016S$1.81 B94.32%
2015S$0.93 B97.67%
2014S$0.47 B23.39%
2013S$0.38 B42.26%
2012S$0.26 B

End of Day market cap according to different sources

On Oct 3rd, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

S$3.15 Billion
by Nasdaq info icon info icon
S$3.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$789.08 B 24,904.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$217.19 B 6,782.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.302 T 41,183.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$159.74 B 4,962.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
S$1.91 B-39.20%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
S$29.71 B 841.58%๐Ÿ‡บ๐Ÿ‡ธ USA